Posted in FINANCE AstraZeneca Breast-Cancer Drug Shown to Slow Tumor Progression June 6, 2022 A new study showed Enhertu cut the risk of tumor progression by half for people with the most advanced form of the disease, offering the prospect of a new treatment for one of the most widely diagnosed cancers. …read more https://www.wsj.com/articles/astrazeneca-breast-cancer-drug-shown-to-slow-tumor-progression-11654514136?mod=pls_whats_news_us_business_f